Digital Health Startups

Neurobell develops AI-powered medical technology for continuous monitoring of neonatal brain activity in neonatal intensive care units. The company combines clinical expertise with machine learning to advance neonatal brain monitoring capabilities.

1 investor

NeuroChat is a brain-computer interface platform that lets people with severe motor and speech impairments (cerebral palsy, ALS, stroke, multiple sclerosis, neurotrauma) type text and communicate through mental effort, with built-in online translation between languages. It also serves as a neurotraining system for developing cognitive functions such as attention, memory, and reaction speed by analyzing EEG data via a hardware headset and software interface.</parameter> <parameter name="founders">[{"full_name": "Наталия Галкина", "title": "Генеральный директор (CEO)"}, {"full_name": "Александр Лужин", "title": "Руководитель НИОКР НейроЧат"}, {"full_name": "Алеся Чичинкина", "title": "Директор по коммуникациям и международному развитию"}, {"full_name": "Юрий Мустафин", "title": "Технический директор (CTO)"}, {"full_name": "Александр Каплан", "title": "Научный руководитель проекта"}, {"full_name": "Игорь Зимин", "title": "Директор по развитию бизнеса"}, {"full_name": "Галина Ершова", "title": "Руководитель патронажной службы"}]

1 investor

NeuroDex develops blood-based biomarkers and diagnostic assays for neurological diseases, including rare genetic disorders, Parkinson's disease, Alzheimer's disease, and ALS. The company works with biopharmaceutical companies to enable patient selection, treatment monitoring, and accelerated disease diagnosis in clinical development programs.

1 investor

NeuroEquilibrium operates a network of clinics specializing in diagnosis and treatment of vertigo, dizziness, and balance disorders through a deep-tech platform that integrates cloud technology, computer vision, and remote diagnostics. The company serves patients and healthcare providers in India and globally, aiming to standardize care for vestibular disorders.

1 investor

Neurofit is a web-based cognitive rehabilitation platform that enables clinicians to assign adaptive cognitive activities, track client performance data, and generate clinical reports for insurance claims. It serves occupational therapists, speech-language pathologists, neuropsychologists, and rehabilitation medicine professionals treating clients across the lifespan.

1 investor

Neurogene develops gene therapy treatments for rare neurological diseases. The company aims to make severe genetic neurological conditions treatable for patients and families impacted by these conditions.

1 investor

NeuroGevity develops a sleep headband with biometric sensors and AI algorithms to assess brain health and detect neurophysiological biomarkers at home. The company also offers sound-based stimulation synchronized to brain activity to enhance slow-wave sleep and memory consolidation.

1 investor

NeuroKaire uses cellular modeling and biological measurement to help mental health providers and patients make treatment decisions for depression based on measurable biological response rather than trial-and-error approaches. The company offers diagnostic testing through CLIA-certified laboratories to provide earlier biological context for antidepressant selection.

1 investor

NeuroSigma is a bioelectronic medical device company that makes non-invasive external trigeminal-nerve stimulation systems to treat chronic neurological and neuropsychiatric disorders. Its Monarch eTNS System is an FDA-cleared, prescription home-use device for treating pediatric ADHD in children ages 7 to 12, with additional programs targeting conditions such as autism spectrum disorder, epilepsy, and depression.</parameter> <parameter name="founders">[]

1 investor

NeuroTx develops AI-powered electroceutical and neurotechnology solutions that use neural decoding and non-invasive vagus nerve stimulation to support sleep quality, cognitive function, and metabolic health. The company integrates wearable devices, mobile applications, and machine learning to deliver personalized bio-signal-based interventions for consumers and patients.

1 investor

1 investor

NeuroVirt provides mixed reality therapy software for stroke and neurorehabilitation, offering gamified exercises for upper and lower limb recovery in clinical and home settings with real-time motion tracking and clinician dashboards.

1 investor

NeuroZen develops AI-based neuroimaging and genetic tools to predict, quantify, and monitor Alzheimer's disease and neurodegeneration, using multimodal clinical, neuropsychological, MRI, PET, and genomic data. Its products include AlzgenAI (genomic risk prediction), MemoAI (tablet-based cognitive testing), and NeuroAI (MRI/APOE-based amyloid PET positivity prediction), aimed at physicians for clinical decision-making, with a focus on Korean and Asian dementia cohorts.

1 investor

An independent nonprofit academic research institution that convenes talent from academic, research, and medical institutions to advance collaborative genomic research and accelerate discoveries in the genetic basis of disease for clinical diagnosis and treatment.

1 investor

New Day Healthcare invests in home care and hospice businesses, providing capital and operational expertise from seasoned industry leaders to support patient-centered outcomes. The firm partners with home care operators who share its values of clinical quality, financial responsibility, and mission-driven stewardship.

1 investor

NewGen Health is developing an at-home care management platform, including a SmartCup device that analyzes urine samples and vital signs at home, with results and trends shared with patients' care teams via cloud storage and EMR integration. It targets monitoring for chronic kidney disease, expectant mothers, and diabetes/cardio-metabolic care, with a stated focus on health equity and accessible care.

1 investor

Newronika is a spin-off of Italian research institutions Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and the University of Milan that develops adaptive deep brain stimulation (αDBS) technology which responds to brain activity in real time. Its neuromodulation systems target Parkinson's disease and are being studied for a broader range of brain disorders, serving clinicians and patients.

1 investor

Newself connects individuals with therapists through an AI-powered platform that helps clients track emotions and patterns while providing therapists with insights to streamline care delivery. The company targets both patients and mental health professionals seeking more connected, efficient therapy experiences.

1 investor

Newton is an innovation company that develops therapeutic optical lenses for treating eye-related conditions like headaches, motion sickness, and neck pain caused by eye misalignment. The company serves optometrists and patients across North America and Europe in the healthcare and optical devices sector.

1 investor

NexCure partners with health systems to build and operate outpatient treatment centers focused on delivering advanced cancer therapies such as CAR-T and T-cell engagers. Its platform combines AI-powered patient selection, remote monitoring, and standardized clinical protocols to bring these treatments to patients in outpatient settings across the country.

1 investor

Nexkin Medical designs and manufactures medical devices and systems for allergology testing. The company develops patient-centric digital health solutions aimed at improving allergy diagnosis and management.

1 investor

Nexmedis offers an AI-powered Health Information System (HIS) for medical facilities, including clinical decision support that suggests differential diagnoses and real-time patient data access. It also transcribes doctor-patient consultations in real time and organizes them into the SOAP framework.

1 investor

NEXOD develops dental CAD/CAM products for chairside dentistry, including the NEXOD M1 milling machine and the COMFORT+ intraoral scanner, along with a digital workflow system for one-day dental treatments. The company's products are manufactured in Korea and target dental practices.

1 investor

Next Innovation Inc. provides telemedicine and remote healthcare services in Japan. The company develops healthcare platforms and offers consulting services to medical institutions.

1 investor